Carbohydrate Sports Nutrition (Maltodextrin, Glucose-Fructose & Hydrogels)

1. Generic or Accepted Substance Name & Classifications

Accepted Name: Carbohydrate Sports Nutrition (Maltodextrin, Glucose-Fructose & Hydrogels)
Common Names, Synonyms & Classifications: Dextrose (D-Glucose) IP; Maltodextrin; Dual-Transportable Carbohydrate (Glucose + Fructose 2:1 / 1:0.8); Alginate-Pectin Hydrogels
Section Classification: Group A — Evidence-Supported Sports Nutrition & Ergogenic Aids (PERF-A06)

2. Pharmacological Class

Macronutrient Glycogen Substrate & Enterocyte SGLT1 / GLUT5 Dual-Transporter Ergogenic Fuel

3. Mechanism of Action

Maintains euglycaemia, spares hepatic glycogen, and sustains high rates of exogenous carbohydrate oxidation during prolonged endurance exercise (>60–90 minutes). Because intestinal apical SGLT1 (Sodium-Glucose Linked Transporter 1) saturates at ~60 g/hour of glucose/maltodextrin alone, combining glucose/maltodextrin with fructose (which uses the independent apical GLUT5 transporter) allows total exogenous carbohydrate absorption and oxidation rates of up to 90 g/hour in ultra-endurance events (>2.5 hours). Even brief carbohydrate mouth rinsing activates oral pharyngeal taste-receptor pathways to the striatum/anterior cingulate cortex, reducing central fatigue in 45–60 min bouts.

4. Proposed Performance or Endurance Effects (Pharmacological Effect vs Proven Athletic Outcome)

Pharmacological/Physiological Effect: Prevents exercise-induced hypoglycaemia and central/peripheral glycogen depletion ('bonking'). Proven Athletic Performance Benefit: Gold-standard, Grade A evidence for delaying fatigue and improving endurance capacity in events >60 minutes (30–60 g/h for 1–2.5 h events; up to 60–90 g/h of multiple transportable carbohydrates for >2.5 h events). Unsupported Claims: Unnecessary for short resistance workouts (<45 minutes) in well-fed athletes and can cause rebound hyperinsulinaemic symptoms if hypertonic simple sugars are taken without warmup adjustments in susceptible individuals.

5. Quality of Scientific Evidence

Evidence Assessment: High / Level A Consensus (IOC, ACSM & ISSN Sports Nutrition Consensus Guidelines)

6. Approved Medical Uses (Where Applicable)

Anhydrous Glucose (Dextrose) IP is an NLEM 2022 / IP 2022 essential medicine for acute hypoglycaemia and WHO Oral Rehydration Salts (ORS).

7. Sports-Related Uses, Misuse Patterns & Contamination Risks

Isotonic sports drinks (6–8% w/v carbohydrate), energy gels, chews, and sodium-alginate hydrogels. Misuse includes ingesting hyperconcentrated (>10–12% w/v) simple sugar solutions without sufficient water during hot marathons, which delays gastric emptying, draws water osmotically into the intestinal lumen, and triggers splanchnic ischaemic cramping and diarrhoea.

8. Adverse Effects & Serious Safety Risks

Osmotic gastrointestinal distress (bloating, nausea, flatulence, osmotic diarrhoea—especially in individuals with fructose malabsorption if fructose exceeds GLUT5 capacity), dental caries/erosion from frequent acidic gel exposure without water rinsing, and hyperglycaemia in insulin-resistant individuals.

9. Contraindications & Precautions

Uncontrolled diabetes mellitus (requires individualised insulin/glucose monitoring), hereditary fructose intolerance (avoid fructose-containing dual blends).

10. Drug Interactions

Co-ingestion with sodium facilitates SGLT1 symport transport (2 Na⁺ : 1 D-glucose + ~260 water molecules); alpha-glucosidase inhibitors (Acarbose, Voglibose) block complex carbohydrate/sucrose digestion (use pure D-glucose if treating hypoglycaemia).

11. Clinical & Laboratory Monitoring Considerations

Practise 'gut training' during endurance preparation; rinse mouth with plain water after acidic carbohydrate gels to protect dental enamel; monitor capillary/CGM glucose in athletes with Type 1 diabetes.

12. Dependence, Misuse or Withdrawal Concerns

No pharmacological dependence.

13. Regulatory & Legal Status in India (CDSCO / Drugs Rules / NDPS / FSSAI)

Dextrose IP is official in IP 2022; commercial sports drinks and energy gels are regulated under FSSAI Food for Special Dietary Uses (FSDU) for sportspersons in India.

14. Official WADA Prohibited-List Status

NOT PROHIBITED via oral ingestion. CRITICAL WADA M2 RULE: Intravenous (IV) infusions and/or injections of >100 mL per 12-hour period of any fluid (including IV Dextrose or saline) are PROHIBITED AT ALL TIMES under WADA Method M2.2 unless legitimately received in the course of hospital treatment, surgical procedures, or clinical diagnostic investigations.

15. Authoritative Source References & Date of Last Verification